EUS-guided drainage of large walled-off pancreatic necroses using plastic versus lumen-apposing metal stents: A single-centre randomised controlled trial

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

EUS-guided drainage of large walled-off pancreatic necroses using plastic versus lumen-apposing metal stents : A single-centre randomised controlled trial. / Karstensen, John Gásdal; Novovic, Srdan; Hansen, Erik Feldager; Jensen, Annette Bojer; Jorgensen, Henrik Lovendahl; Lauritsen, Morten Laksafoss; Werge, Mikkel Parsberg; Schmidt, Palle Nordblad.

In: Gut, Vol. 72, No. 6, 2023, p. 1167-1173.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Karstensen, JG, Novovic, S, Hansen, EF, Jensen, AB, Jorgensen, HL, Lauritsen, ML, Werge, MP & Schmidt, PN 2023, 'EUS-guided drainage of large walled-off pancreatic necroses using plastic versus lumen-apposing metal stents: A single-centre randomised controlled trial', Gut, vol. 72, no. 6, pp. 1167-1173. https://doi.org/10.1136/gutjnl-2022-328225

APA

Karstensen, J. G., Novovic, S., Hansen, E. F., Jensen, A. B., Jorgensen, H. L., Lauritsen, M. L., Werge, M. P., & Schmidt, P. N. (2023). EUS-guided drainage of large walled-off pancreatic necroses using plastic versus lumen-apposing metal stents: A single-centre randomised controlled trial. Gut, 72(6), 1167-1173. https://doi.org/10.1136/gutjnl-2022-328225

Vancouver

Karstensen JG, Novovic S, Hansen EF, Jensen AB, Jorgensen HL, Lauritsen ML et al. EUS-guided drainage of large walled-off pancreatic necroses using plastic versus lumen-apposing metal stents: A single-centre randomised controlled trial. Gut. 2023;72(6):1167-1173. https://doi.org/10.1136/gutjnl-2022-328225

Author

Karstensen, John Gásdal ; Novovic, Srdan ; Hansen, Erik Feldager ; Jensen, Annette Bojer ; Jorgensen, Henrik Lovendahl ; Lauritsen, Morten Laksafoss ; Werge, Mikkel Parsberg ; Schmidt, Palle Nordblad. / EUS-guided drainage of large walled-off pancreatic necroses using plastic versus lumen-apposing metal stents : A single-centre randomised controlled trial. In: Gut. 2023 ; Vol. 72, No. 6. pp. 1167-1173.

Bibtex

@article{3ecfd043327548d7b19d78f6cecc708d,
title = "EUS-guided drainage of large walled-off pancreatic necroses using plastic versus lumen-apposing metal stents: A single-centre randomised controlled trial",
abstract = "Objective: In treating pancreatic walled-off necrosis (WON), lumen-apposing metal stents (LAMS) have not proven superior to the traditional double pigtail technique (DPT). Among patients with large WON (>15 cm) and their associated substantial risk of treatment failure, the increased drainage capacity of a novel 20-mm LAMS might improve clinical outcomes. Hence, we conducted a study comparing the DPT and 20-mm LAMS in patients with large WON. Design: A single-centre, open-label, randomised, controlled superiority trial using an endoscopic step-up approach in patients with WON exceeding 15 cm in size. The primary endpoint was the number of necrosectomies needed to achieve clinical success (clinical and CT resolution), while the secondary endpoints included technical success, adverse events, length of stay and mortality. Results: Twenty-two patients were included in the DPT group and 20 in the LAMS group, with no significant differences in patient characteristics. The median size of WON was 24.1 cm (P25-P75: 19.6-31.1). The technical success rates were 100% for DPT and 95% for LAMS (p=0.48), while clinical success rates were 95.5% and 94.7%, respectively (p=1.0). The mean number of necrosectomies was 2.2 for DPT and 3.2 for LAMS (p=0.42). Five patients (12%) developed procedure-related serious adverse events (DPT=4, LAMS=1, p=0.35). The median length of stay was 43 (P25-P75: 40-67) and 58 days (P25-P75: 40-86) in the DPT and LAMS groups (p=0.71), respectively, with an overall mortality of 4.8%. Conclusions: For treating large WON, LAMS are not superior to DPT. The techniques are associated with comparable needs for necrosectomy and hospital stay, and no gross difference in adverse events. Trial registration number: NCT04057846.",
keywords = "acute pancreatitis, endoscopic ultrasonography",
author = "Karstensen, {John G{\'a}sdal} and Srdan Novovic and Hansen, {Erik Feldager} and Jensen, {Annette Bojer} and Jorgensen, {Henrik Lovendahl} and Lauritsen, {Morten Laksafoss} and Werge, {Mikkel Parsberg} and Schmidt, {Palle Nordblad}",
note = "Publisher Copyright: {\textcopyright} 2022 Author(s). Published by BMJ.",
year = "2023",
doi = "10.1136/gutjnl-2022-328225",
language = "English",
volume = "72",
pages = "1167--1173",
journal = "Gut",
issn = "0017-5749",
publisher = "B M J Group",
number = "6",

}

RIS

TY - JOUR

T1 - EUS-guided drainage of large walled-off pancreatic necroses using plastic versus lumen-apposing metal stents

T2 - A single-centre randomised controlled trial

AU - Karstensen, John Gásdal

AU - Novovic, Srdan

AU - Hansen, Erik Feldager

AU - Jensen, Annette Bojer

AU - Jorgensen, Henrik Lovendahl

AU - Lauritsen, Morten Laksafoss

AU - Werge, Mikkel Parsberg

AU - Schmidt, Palle Nordblad

N1 - Publisher Copyright: © 2022 Author(s). Published by BMJ.

PY - 2023

Y1 - 2023

N2 - Objective: In treating pancreatic walled-off necrosis (WON), lumen-apposing metal stents (LAMS) have not proven superior to the traditional double pigtail technique (DPT). Among patients with large WON (>15 cm) and their associated substantial risk of treatment failure, the increased drainage capacity of a novel 20-mm LAMS might improve clinical outcomes. Hence, we conducted a study comparing the DPT and 20-mm LAMS in patients with large WON. Design: A single-centre, open-label, randomised, controlled superiority trial using an endoscopic step-up approach in patients with WON exceeding 15 cm in size. The primary endpoint was the number of necrosectomies needed to achieve clinical success (clinical and CT resolution), while the secondary endpoints included technical success, adverse events, length of stay and mortality. Results: Twenty-two patients were included in the DPT group and 20 in the LAMS group, with no significant differences in patient characteristics. The median size of WON was 24.1 cm (P25-P75: 19.6-31.1). The technical success rates were 100% for DPT and 95% for LAMS (p=0.48), while clinical success rates were 95.5% and 94.7%, respectively (p=1.0). The mean number of necrosectomies was 2.2 for DPT and 3.2 for LAMS (p=0.42). Five patients (12%) developed procedure-related serious adverse events (DPT=4, LAMS=1, p=0.35). The median length of stay was 43 (P25-P75: 40-67) and 58 days (P25-P75: 40-86) in the DPT and LAMS groups (p=0.71), respectively, with an overall mortality of 4.8%. Conclusions: For treating large WON, LAMS are not superior to DPT. The techniques are associated with comparable needs for necrosectomy and hospital stay, and no gross difference in adverse events. Trial registration number: NCT04057846.

AB - Objective: In treating pancreatic walled-off necrosis (WON), lumen-apposing metal stents (LAMS) have not proven superior to the traditional double pigtail technique (DPT). Among patients with large WON (>15 cm) and their associated substantial risk of treatment failure, the increased drainage capacity of a novel 20-mm LAMS might improve clinical outcomes. Hence, we conducted a study comparing the DPT and 20-mm LAMS in patients with large WON. Design: A single-centre, open-label, randomised, controlled superiority trial using an endoscopic step-up approach in patients with WON exceeding 15 cm in size. The primary endpoint was the number of necrosectomies needed to achieve clinical success (clinical and CT resolution), while the secondary endpoints included technical success, adverse events, length of stay and mortality. Results: Twenty-two patients were included in the DPT group and 20 in the LAMS group, with no significant differences in patient characteristics. The median size of WON was 24.1 cm (P25-P75: 19.6-31.1). The technical success rates were 100% for DPT and 95% for LAMS (p=0.48), while clinical success rates were 95.5% and 94.7%, respectively (p=1.0). The mean number of necrosectomies was 2.2 for DPT and 3.2 for LAMS (p=0.42). Five patients (12%) developed procedure-related serious adverse events (DPT=4, LAMS=1, p=0.35). The median length of stay was 43 (P25-P75: 40-67) and 58 days (P25-P75: 40-86) in the DPT and LAMS groups (p=0.71), respectively, with an overall mortality of 4.8%. Conclusions: For treating large WON, LAMS are not superior to DPT. The techniques are associated with comparable needs for necrosectomy and hospital stay, and no gross difference in adverse events. Trial registration number: NCT04057846.

KW - acute pancreatitis

KW - endoscopic ultrasonography

U2 - 10.1136/gutjnl-2022-328225

DO - 10.1136/gutjnl-2022-328225

M3 - Journal article

C2 - 36446550

AN - SCOPUS:85144454400

VL - 72

SP - 1167

EP - 1173

JO - Gut

JF - Gut

SN - 0017-5749

IS - 6

ER -

ID: 332253049